Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP292883.RA6D1-OR2Wogybotm1l2McPxTkn5bEEyaeyZn2M6c_D5E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP292883.RA6D1-OR2Wogybotm1l2McPxTkn5bEEyaeyZn2M6c_D5E130_assertion type Assertion NP292883.RA6D1-OR2Wogybotm1l2McPxTkn5bEEyaeyZn2M6c_D5E130_head.
- NP292883.RA6D1-OR2Wogybotm1l2McPxTkn5bEEyaeyZn2M6c_D5E130_assertion description "[In this study we show that ROS1 is abnormally activated in the CD34+ compartment of approximately 70% of CMML patients resulting in the activation of the Erk/Akt pathways through the Grb2/SOS complex thus revealing a central oncogenic role for ROS1 in CMML which might represent a molecular target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP292883.RA6D1-OR2Wogybotm1l2McPxTkn5bEEyaeyZn2M6c_D5E130_provenance.
- NP292883.RA6D1-OR2Wogybotm1l2McPxTkn5bEEyaeyZn2M6c_D5E130_assertion evidence source_evidence_literature NP292883.RA6D1-OR2Wogybotm1l2McPxTkn5bEEyaeyZn2M6c_D5E130_provenance.
- NP292883.RA6D1-OR2Wogybotm1l2McPxTkn5bEEyaeyZn2M6c_D5E130_assertion SIO_000772 23415111 NP292883.RA6D1-OR2Wogybotm1l2McPxTkn5bEEyaeyZn2M6c_D5E130_provenance.
- NP292883.RA6D1-OR2Wogybotm1l2McPxTkn5bEEyaeyZn2M6c_D5E130_assertion wasDerivedFrom befree-20150227 NP292883.RA6D1-OR2Wogybotm1l2McPxTkn5bEEyaeyZn2M6c_D5E130_provenance.
- NP292883.RA6D1-OR2Wogybotm1l2McPxTkn5bEEyaeyZn2M6c_D5E130_assertion wasGeneratedBy ECO_0000203 NP292883.RA6D1-OR2Wogybotm1l2McPxTkn5bEEyaeyZn2M6c_D5E130_provenance.